Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 10Breast 7Genitourinary 5Gastrointestinal 5Thoracic 3Head & Neck 3Gynecologic 3CNS 3Tumor-Agnostic 2Plasma cell 2Myeloid 2Lymphoid 2Other solid neoplasm 1Other hematologic neoplasm 1NET 1Endocrine 1Classical hematology 1

Conditions

Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Nasopharyngeal Carcinoma 4Ovarian Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Recurrence 2Penile Neoplasms 2Neoplasms 2Hodgkin Disease 2Carcinoma, Squamous Cell 2Anus Neoplasms 2Uveal Melanoma 1Thyroid Neoplasms 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Pheochromocytoma 1Paraganglioma 1Papillomavirus Infections 1Neuroendocrine Tumors 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 35Cetuximab 18Gemcitabine 14Nivolumab 13Cisplatin 13Paclitaxel 10Carboplatin 9Cyclophosphamide 7cemiplimab 6Fluorouracil 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Docetaxel 5fludarabine 4durvalumab 4aldesleukin 4Immune Checkpoint Inhibitors 4Biopsy 4fludarabine phosphate 3Valproic Acid 3Radiation 3Interleukin-2 3Drug Therapy 3Bevacizumab 3130-nm albumin-bound paclitaxel 3tislelizumab 2sintilimab 2avelumab 2apatinib 2Tablets 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × fludarabine phosphate × Head & Neck × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡